Methylglyoxal Impairs Insulin Secretion of Pancreaticβ-Cells through Increased Production of ROS and Mitochondrial Dysfunction Mediated by Upregulation of UCP2 and MAPKs
Authors:
Open Access
- 1 January 2016
- journal article
- research article
- Published by Wiley in Journal of Diabetes Research
- Vol. 2016, 1-14
Abstract
Methylglyoxal (MG) is a highly reactive glucose metabolic intermediate and a major precursor of advanced glycation end products. MG level is elevated in hyperglycemic disorders such as diabetes mellitus. Substantial evidence has shown that MG is involved in the pathogenesis of diabetes and diabetic complications. We investigated the impact of MG on insulin secretion by MIN6 and INS-1 cells and the potential mechanisms of this effect. Our study demonstrates that MG impaired insulin secretion by MIN6 or ISN-1 cells in a dose-dependent manner. It increased reactive oxygen species (ROS) production and apoptosis rate in MIN6 or ISN-1 cells and inhibited mitochondrial membrane potential (MMP) and ATP production. Furthermore, the expression of UCP2, JNK, and P38 as well as the phosphorylation JNK and P38 was increased by MG. These effects of MG were attenuated by MG scavenger N-acetyl cysteine. Collectively, these data indicate that MG impairs insulin secretion of pancreaticβ-cells through increasing ROS production. High levels of ROS can damageβ-cells directly via JNK/P38 upregulation and through activation of UCP2 resulting in reduced MMP and ATP production, leading toβ-cell dysfunction and impairment of insulin production.Keywords
Funding Information
- National Natural Science Foundation of China (81170257)
This publication has 36 references indexed in Scilit:
- The chemistry and biological activities of N-acetylcysteineBiochimica et Biophysica Acta (BBA) - General Subjects, 2013
- Reduction of Methylglyoxal-Induced Glycation by Pyridoxamine Improves Adipose Tissue Microvascular LesionsJournal of Diabetes Research, 2013
- The Role of Uncoupling Proteins in Diabetes MellitusJournal of Diabetes Research, 2013
- Methylglyoxal promotes oxidative stress and endothelial dysfunctionPharmacological Research, 2012
- Chronic Methylglyoxal Infusion by Minipump Causes Pancreatic β-Cell Dysfunction and Induces Type 2 Diabetes in Sprague-Dawley RatsDiabetes, 2011
- Oxidative Stress and Diabetic ComplicationsCirculation Research, 2010
- Methylglyoxal scavengers attenuate endothelial dysfunction induced by methylglyoxal and high concentrations of glucoseBritish Journal of Pharmacology, 2010
- Regulation of insulin secretion: role of mitochondrial signallingDiabetologia, 2010
- Fructose-induced peroxynitrite production is mediated by methylglyoxal in vascular smooth muscle cellsLife Sciences, 2006
- Islet cell failure in type 2 diabetesJournal of Clinical Investigation, 2006